header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

PAPER 082: CRITICAL SEGMENTAL DEFECT REGENERATION USING BIODEGRADABLE, LOAD BEARING SCAFFOLD CONTAINING BMP-2 IN A CANINE MODEL



Abstract

Purpose: One of the most difficult challenges for orthopaedic surgeons is the management of bone loss resulting in a segmental bone defect. Segmental bone defects are ubiquitously difficult to treat, require multi-phase surgery and have frequent complications. A promising new strategy involves combining tissue engineering techniques with the delivery of biologically active proteins to facilitate bone regeneration. The purpose of this study is twofold:

  1. First, to investigate whether a cylindrical, biodegradable load-bearing scaffold, stabilized with an intramedullary (IM) nail, will facilitate early weight bearing in a critical sized canine defect model.

  2. The second objective is to investigate if rhBMP-2, transported by the biodegradable carrier, will enhance bone formation and healing across a critical sized canine defect.

Method: A critical size defect of 3 cm was created in the canine tibia by osteotomy. A cylindrical, biodegradable scaffold of (poly) propylene fumarate was inserted into the defect and the tibia was stabilized with a locked intramedullary nail. Half of the scaffolds were impregnated with 300μg rhBMP-2 and half remained as controls. The animals were allowed immediate weight bearing post-operatively. X-rays were obtained post-operatively and at weeks 1, 2, 3, 6, 12, 18, and 24. X-rays were assessed for loss of height, integrity of the scaffold, and presence of bridging callous formation.

Results: The animals that received scaffolds treated with rhBMP-2 showed abundant callus formation on X-ray. Partial bridging callus formation in this group was seen at 3 weeks. Complete bridging callus (bridging on 4 cortices) was observed by 6 weeks. These specimens maintained height of the defect and overall length of the tibia. Controls demonstrated minimal callus formation at all time points. By 3 weeks significant loss of defect height was observed. By 6 weeks failure of hardware (breakage of interlocking screws and/or screw loosening) was evident.

Conclusion: This study shows that biodegradable scaffolds, treated with rhBMP-2 and implanted in a critical sized defect facilitate bridging callus formation and healing across the defect. This data indicates that biodegradable scaffolds made of (poly) propylene fumarate are suitable carriers for rhBMP-2 while providing initial structural support for weight bearing.

Correspondence should be addressed to Meghan Corbeil, Meetings Coordinator Email: meghan@canorth.org